SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000909661-04-000077
Filing Date
2004-06-25
Accepted
2004-06-25 17:14:36
Documents
1
Group Members
CHARLES E. ELLWEINCHUN R. DINGDAVID I. COHENDEREK C. SCHRIERFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL PARTNERS, L.P.FARALLON PARTNERS, L.L

Document Format Files

Seq Description Document Type Size
1 npsp13g.txt SC 13G 85002
  Complete submission text file 0000909661-04-000077.txt   87653
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44877 | Film No.: 04882753
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE MARITIME PLAZA SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA STE 11325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279